The Efficacy of a Subanesthetic Doses of IV Ketamine in the Treatment Drug Resistant Epilepsy
Status:
Not yet recruiting
Trial end date:
2024-07-01
Target enrollment:
Participant gender:
Summary
Ketamine is a medication that came into clinical practice in the 1960's. Ketamine is used as
an anesthetic and to provide pain relief. Recently, Ketamine was approved to treat drug
resistant depression using subanesthetic doses. In the hospital setting, intravenous
anesthetic dosages are used to treat unrelenting seizures known as status epilepticus in
comatose patients. Ketamine in subanesthetic doses has not been tried as a treatment for
medication resistant seizures in the outpatient setting. This study would like to examine the
effectiveness of subanesthetic ketamine in outpatients who suffer from drug resistant
epilepsy.